HeartSciences (HSCS) Depreciation and Depletion (2021 - 2026)
HeartSciences (HSCS) posted quarterly Depreciation and Depletion of $6758.0 for Q2 2026, down 10.05% year-on-year from $7513.0 in Q2 2025, and down 3.54% on a QoQ basis from $7006.0 in Q4 2025.
HeartSciences (HSCS) Depreciation and Depletion (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Depreciation and Depletion for 6 consecutive years, with $6758.0 the latest figure, recorded in Q2 2026.
- Quarterly Depreciation and Depletion fell 10.05% year-over-year to $6758.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $28388.0 (down 24.5% YoY) and the FY2026 annual result came in at $27791.0, down 26.09% from the prior year.
- Depreciation and Depletion fell to $6758.0 in Q2 2026 per HSCS's latest filing, from $7006.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for HSCS reached as high as $12215.0 in Q4 2024 and fell as low as $3717.0 in Q1 2024.
- A 5-year average of $7427.8 and a median of $6865.0 in 2023 frame the typical range for Depreciation and Depletion.
- The largest YoY upside for Depreciation and Depletion was 61.68% in 2024 against a maximum downside of 45.86% in 2024.
- Year by year, Depreciation and Depletion stood at $6813.0 in 2022, then gained by 12.08% to $7636.0 in 2023, then jumped by 59.97% to $12215.0 in 2024, then plunged by 42.64% to $7006.0 in 2025, then dropped by 3.54% to $6758.0 in 2026.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $6758.0, $7006.0, and $7111.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | 6,758.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 6,758.00 |
| Apr 30, 2026 | 6,758.00 |
| Oct 31, 2025 | 7,006.00 |
| Oct 31, 2025 | 7,006.00 |
| Jul 31, 2025 | 7,111.00 |
| Jul 31, 2025 | 7,111.00 |
| Apr 30, 2025 | 7,513.00 |
| Apr 30, 2025 | 7,513.00 |
| Jan 31, 2025 | 6,007.00 |
| Jan 31, 2025 | 6,007.00 |
| Oct 31, 2024 | 12,215.00 |
| Oct 31, 2024 | 12,215.00 |
| Jul 31, 2024 | 11,864.00 |
| Jul 31, 2024 | 11,864.00 |
| Apr 30, 2024 | 9,201.00 |
| Apr 30, 2024 | 9,201.00 |
| Jan 31, 2024 | 3,717.00 |
| Jan 31, 2024 | 3,717.00 |
| Oct 31, 2023 | 7,636.00 |
| Oct 31, 2023 | 7,636.00 |